General Information:

Id: 1,832
Diseases: Epilepsy, temporal lobe
Status epilepticus
Rattus norvegicus
article
Reference: Waldbaum S et al.(2010) Persistent impairment of mitochondrial and tissue redox status during lithium-pilocarpine-induced epileptogenesis J. Neurochem. 115: 1172-1182 [PMID: 21219330]

Interaction Information:

Comment The treatment by pilocarpine leads to the convulsive seizures of Sprague-Dawley rat.
Formal Description
Interaction-ID: 13845

drug/chemical compound

Pilocarpine

affects_activity of

Drugbank entries Show/Hide entries for Pilocarpine
Comment After lithium-pilocarpine treatment of hippocampus and neocortex the time-dependent increase in mitochondrial hydrogen peroxide (H2O2) production coincident with increased mtDNA lesion frequency.
Formal Description
Interaction-ID: 13866

increases_quantity of

drug/chemical compound

H2O2

Comment Acute increases (24-48 h) in H2O2 produc tion and mtDNA lesion frequency were dependent on the severity of convulsive seizure activity during initial status epilepticus.
Formal Description
Interaction-ID: 13867

decreases_activity of

Comment Tissue levels of GSH, GSH/GSSG, coenzyme A (CoASH), and CoASH/CoASSG were persistently impaired at all measured time points throughout epileptogenesis, that is, acutely (24-48 h), during the latent period (48 h to 7 days), and chronic epilepsy (21 days to 3 months.
Formal Description
Interaction-ID: 13868

process

epileptogenesis

increases_quantity of

drug/chemical compound

Glutathione

Drugbank entries Show/Hide entries for
Comment Tissue levels of GSH, GSH/GSSG, coenzyme A (CoASH), and CoASH/CoASSG were persistently impaired at all measured time points throughout epileptogenesis, that is, acutely (24-48 h), during the latent period (48 h to 7 days), and chronic epilepsy (21 days to 3 months).
Formal Description
Interaction-ID: 13869

process

epileptogenesis

decreases_quantity of

drug/chemical compound

Glutathione disulfide

Comment Tissue levels of GSH, GSH/GSSG, coenzyme A (CoASH), and CoASH/CoASSG were persistently impaired at all measured time points throughout epileptogenesis, that is, acutely (24-48 h), during the latent period (48 h to 7 days), and chronic epilepsy (21 days to 3 months).
Formal Description
Interaction-ID: 13870

process

epileptogenesis

decreases_quantity of

drug/chemical compound

CoA

Comment Tissue levels of GSH, GSH/GSSG, coenzyme A (CoASH), and CoASH/CoASSG were persistently impaired at all measured time points throughout epileptogenesis, that is, acutely (24-48 h), during the latent period (48 h to 7 days), and chronic epilepsy (21 days to 3 months).
Formal Description
Interaction-ID: 13871

process

epileptogenesis

affects_activity of

Comment After lithium-pilocarpine treatment of hippocampus and neocortex the time-dependent increase in mitochondrial hydrogen peroxide (H2O2) production coincident with increased mtDNA lesion frequency.
Formal Description
Interaction-ID: 13873

affects_activity of